Summary: There is currently no established causal link between GLP-1 weight loss injections and mood swings, though some patients report emotional changes during treatment
Summary: Mounjaro and Lantus can be prescribed together under medical supervision for type 2 diabetes, with insulin dose reduction typically required to minimise hypoglycaemia risk
CCHP March 24, 2026 The Skinny on the Federal Crackdown on GLP-1 Drugs and How Telehealth is Involved (...Or Not!) In early March, the U.S
The glutathione-dependent neuroprotective activity of the blood-CSF barrier is inducible through the Nrf2 signaling pathway during postnatal development

Weight loss effectiveness Average weight loss expectations: 0.5mg daily: 8-10% over 24 weeks 1.0mg daily: 10-12% over 24 weeks Starting weight ~220 lbs: Lose 22-26 lbs Better than most weight loss medications Similar to GLP-1 agonists Individual variation: Timeline for weight loss: Week 1-2: 2-4 lbs (water weight + appetite suppression ) Week 3-4: 1-2 lbs/week (fat loss beginning) Month 2-3: 1-1.5 lbs/week (steady loss) Month 4-6: 0.5-1 lb/week (slowing, approaching plateau) Month 6-9: 0-0.5 lb/week (maintenance/plateau) Total: 20-30 lbs typical over 6 months Body composition changes: Primarily fat loss (75-80% of loss) Some muscle loss (20-25%) - unavoidable in deficit Better muscle preservation than pure caloric restriction Waist circumference reduction significant Visceral fat preferentially lost See peptides before and after results and how long peptides take to work

Functional MRI activation of the nucleus tractus solitarius after taste stimuli at ultra-high field: a proof-of-concept single-subject study